ClinicalTrials.Veeva

Menu

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

NuVasive logo

NuVasive

Status

Completed

Conditions

Cervical Degenerative Disc Disorder

Treatments

Device: Simplify Disc

Study type

Observational

Funder types

Industry

Identifiers

NCT04980378
P200022_S003_PAS

Details and patient eligibility

About

This study is intended to demonstrate the 5-year long-term safety and efficacy of the Simplify® Cervical Artificial Disc ("Simplify Disc") in subjects enrolled in the non-randomized two-level Simplify Disc Investigational Device Exemption (IDE) study. This study was conducted under IDE G150206

Enrollment

291 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

- All subjects enrolled in the two level Simplify Disc IDE study are considered for this long-term follow-up study.

Exclusion criteria

  • Subjects who were not implanted with the Simplify Disc during the IDE study
  • Subjects who had a secondary surgical intervention at the index level during the IDE study
  • Subjects who were withdrawn or withdrew consent to participate in the IDE study
  • Subjects who do not consent to participate in long-term follow-up post-approval study

Trial design

291 participants in 2 patient groups

Simplify Disc
Description:
Extended follow-up of IDE Subjects treated at two continuous levels with the Simplify Cervical Artificial Disc during IDE G150206
Treatment:
Device: Simplify Disc
Historical Control - Anterior Cervical Discectomy and Fusion (ACDF)
Description:
This study used a non-concurrent historical control with subject-level data on a parallel group design. The historical control group was formed from the randomized ACDF arm of a previously completed two level cervical disc trial.

Trial documents
1

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems